electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 07 2023 - 8:00AM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine and wellness company, announced today that Company CEO,
Dan Goldberger, will present at the H.C. Wainwright 25th Annual
Global Investment Conference.
H.C. Wainwright 25th Annual Global Investment
Conference:Date: Monday, September 11, 2023Time:
Recorded presentation available starting at 7:00 am ETEvent:
Company Presentation
For more information regarding the conference and to register,
please visit the conference page here.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine and wellness company
dedicated to improving health through its non-invasive vagus nerve
stimulation (“nVNS”) technology platform. Our focus is the
commercialization of medical devices for the management and
treatment of certain medical conditions and consumer product
offerings utilizing nVNS to promote general wellbeing and human
performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:ECOR Investor Relations(973)
302-9253investors@electrocore.com
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From May 2024 to Jun 2024
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Jun 2023 to Jun 2024